Chronic graft-versus-host disease (GVHD) is the leading cause of late morbidity and
mortality after allogeneic hematopoietic cell transplantation. Symptoms and manifestations …

Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after
lung transplantation. Chronic lung allograft dysfunction manifests as bronchiolitis obliterans …

Clinical outcomes for patients undergoing allogeneic hematopoietic stem cell
transplantation continue to improve, but chronic graft-versus-host disease (GVHD) remains a …

Allogeneic stem cell transplantation is associated with a high risk of treatment-related
mortality mainly caused by infections and graft-versus-host disease (GVHD). GVHD is …

Extracorporeal photopheresis (ECP) is one of the most used and established therapies for
steroid‐refractory graft‐vs‐host disease (GvHD), with a good effect to side effect profile. In …

Acute graft-versus-host disease (aGVHD) is the major cause of morbidity and mortality after
allogeneic hematopoietic stem cell transplantation. Systemic steroid treatment represents …

Introduction: Transplant-related complications are common after allogeneic hematopoietic
stem cell transplantation (allo-HSCT), including graft versus host disease (GVHD). The lungs …

目的探讨输注体外光化学疗法处理的单核细胞对肾移植大鼠排斥反应影响.
方法首先手术建立大鼠肾移植模型, 分离受体大鼠单个核细胞, 制备8⁃ 甲氧基补骨脂素联合 …

Chronic graft-versus-host disease (cGVHD) currently represents the leading cause of
nonrelapse mortality and morbidity after allogeneic hematopoietic stem cell transplantation …

Acute graft-versus-host disease (aGVHD) is a significant complication of allogeneic
hematopoietic stem cell transplant (HSCT) and negatively affects T cell reconstitution …